Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001829126-25-001007
Filing Date
2025-02-14
Accepted
2025-02-14 16:56:59
Documents
1
Effectiveness Date
2025-02-14
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9226
  Complete submission text file 0001829126-25-001007.txt   10525
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-538390 | Film No.: 25630422
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)